Supply Assurance for MedTech & Life Sciences

Continuity for the supplies your operation cannot afford to miss.

ZERTELA is developing a specialized Supply Assurance model for selected materials and consumables used by MedTech and Life Sciences manufacturers in Costa Rica. It is designed to combine reliable sourcing, local availability where justified, quality and documentation support, and responsive replenishment.

See our model

For OEMs · Contract manufacturers · Tier suppliers · Selected Life Sciences operations

Under development · Industry discovery underway in Costa Rica

Representative MedTech professionals reviewing a technical supply requirement

Where supply friction appears

A low-cost item can carry a high continuity risk.

Unit price matters—but so do lead time, qualification effort, working capital and shortage risk.

01

Import dependency

Long international lead times and limited alternatives can turn a recurring item into a service exposure.

02

Qualification effort

Specifications, samples and stakeholder approvals can make switching sources slow and resource-intensive.

03

Documentation readiness

Missing or disconnected technical and quality information can delay evaluation and purchasing decisions.

04

Replenishment flexibility

Rigid order cycles can create avoidable expediting, excess stock or recurring shortage risk.

The ZERTELA model

Four pillars. One continuity objective.

The model is designed around selected requirements—not catalog breadth—and combines only the capabilities that validated customer demand supports.

Reliable sourcing

Assess potential manufacturers and supply routes against technical fit, consistency, capacity and true landed cost.

Local availability

Design local stock or buffer concepts only where service requirements, validated demand and commercial viability justify them.

Quality & documentation support

Coordinate specifications, samples, traceability and required supplier information to support customer-led evaluation.

Responsive replenishment

Explore scheduled replenishment, blanket orders, safety stock and VMI models around actual consumption and validated economics.

A structured path

From requirement to a viable supply plan.

The proposed path connects commercial sourcing decisions with the technical and operational gates expected in regulated manufacturing environments.

01

Requirement capture

Clarify the material, specification, use case, demand pattern, current supply path and service exposure.

02

Source assessment

Screen potential manufacturers and supply routes for technical, quality, capacity and commercial fit.

03

Qualification support

Coordinate samples, documentation and review gates for evaluation led by the customer’s authorized teams.

04

Supply plan

Define a realistic sourcing, availability and replenishment model around the validated requirement.

ZERTELA supports the evaluation process. Final product and supplier approval remain with the customer’s authorized functions.

Institutional overview

See ZERTELA in under 90 seconds.

A concise overview of how ZERTELA approaches supply continuity for MedTech & Life Sciences.

Representative review of cleanroom material and technical documentation

Current discovery scope

Selected categories—not a fixed catalog.

Our initial discovery scope includes recurring imported categories where continuity, documentation and responsiveness may create meaningful value. Customer evidence will determine where ZERTELA builds its initial portfolio.

  1. 01Contamination control & cleanroom consumables
  2. 02Sterile & protective packaging
  3. 03Fluid-path & process components
  4. 04Filtration & process consumables
Portfolio priorities will follow validated demand, technical fit and commercial viability—not a prebuilt product list.

Why ZERTELA

Built from supply-chain expertise. Designed for this ecosystem.

ZERTELA is being built on more than 20 years of senior global and Latin American supply-chain experience across planning, sourcing, inventory and operations.

01

Founder-led

Direct senior involvement in shaping the model, customer discovery and opportunity assessment.

02

Specialized market thesis

A focused study of Costa Rica’s MedTech and Life Sciences ecosystem—not an opportunistic import model.

03

Designed for purpose

A model intended to connect sourcing, quality discipline, availability and replenishment around selected requirements.

Teams in the conversation
ProcurementQuality & RegulatoryOperations & PlanningEngineering & NPI
Representative cross-functional MedTech team reviewing a supply requirement
PROCUREMENT · QUALITY · OPERATIONS · ENGINEERING

A 30-minute industry discovery conversation

Where is your supply continuity most exposed?

Share one recurring material, component or supply path that creates operational exposure. We will use the conversation to understand the current route, qualification requirements, demand pattern and what a new supplier would need to demonstrate.

One-to-one · Exploratory · No commercial commitment · No confidential information required